Genetic testing in Li-Fraumeni syndrome: Uptake and psychosocial consequences

Journal of Clinical Oncology

Volumn 28, Issue 18, 2010, Pages 3008-3014

  Lammens, Chantal R M ^a   Aaronson, Neil K ^a   Wagner, Anja ^a   Sijmons, Rolf H ^a   Ausems, Margreet G E M ^a   Vriends, Annette H J T ^a   Ruijs, Mariëlle W G ^a   Van Os, Theo A M ^a   Spruijt, Liesbeth ^a   Gómez García, Encarna B ^a   Kluijt, Irma ^a   Nagtegaal, Tanja ^a   Verhoef, Senno ^a   Bleiker, Eveline M A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; DISEASE CARRIER; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT COUNSELING; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; ADAPTIVE BEHAVIOR; CONFLICT; CROSS-SECTIONAL STUDY; GENETICS; MENTAL STRESS; MIDDLE AGED; MUTATION; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK FACTOR; SELF CONCEPT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; CONFLICT (PSYCHOLOGY); CROSS-SECTIONAL STUDIES; FEMALE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; MIDDLE AGED; NETHERLANDS; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SELF EFFICACY; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77954572243     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.27.2112     Document Type: Article

References (36)

1. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238, 1990 (Pubitemid 120031831)
2. Hwang SJ, Lozano G, Amos CI, et al: Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk. Am J Hum Genet 72:975-983, 2003 (Pubitemid 36403315)
3. Jarvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000 (Pubitemid 30243745)
4. Narod SA, Offit K: Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656-1663, 2005 (Pubitemid 46211420)
5. Rebbeck TR, Friebel T, Lynch HT, et al: Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J Clin Oncol 22:1055-1062, 2004 (Pubitemid 41095038)
6. Schneider KA: Li Fraumeni Syndrome. Gene Review (www genetests org). 2004
7. Varley JM, Evans DG, Birch JM: Li-Fraumeni syndrome-a molecular and clinical review. Br J Cancer 76:1-14, 1997 (Pubitemid 27250068)
8. Eng C, Hampel H, de la Chapelle A: Genetic testing for cancer predisposition. Annu Rev Med 52:371-400, 2001 (Pubitemid 32195331)
9. Netherlands Foundation for the Detection of Hereditary Tumours, Dutch Society for Clinical Genetics: Hereditary Cancer: Diagnostic and Preventive Guidelines (ed 3). Leiden, the Netherlands Foundation for the Detection of Hereditary Tumours, Dutch Society for Clinical Genetics, 2005, pp 14-16
10. Evans DG, Maher ER, Macleod R, et al: Uptake of genetic testing for cancer predisposition. J Med Genet 34:746-748, 1997 (Pubitemid 27406196)
11. Patenaude AF, Schneider KA, Kieffer SA, et al: Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing. Psycho-oncology 5:241-250, 1996
12. Peterson SK, Pentz RD, Marani SK, et al: Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome. Psychooncology 17:783-789, 2008
13. Broadstock M, Michie S, Marteau T: Psychological consequences of predictive genetic testing: A systematic review. Eur J Hum Genet 8:731-738, 2000
14. Meiser B: Psychological impact of genetic testing for cancer susceptibility: An update of the literature. Psychooncology 14:1060-1074, 2005
15. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, et al: Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 355:2015-2020, 2000 (Pubitemid 30339238)
16. Ropka ME, Wenzel J, Phillips EK, et al: Uptake rates for breast cancer genetic testing: A systematic review. Cancer Epidemiol Biomarkers Prev 15:840-855, 2006 (Pubitemid 43823507)
17. Wagner A, Tops C, Wijnen JT, et al: Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation J Med Genet 39:833-837, 2002 (Pubitemid 35346954)
18. Brom D, Kleber RJ: Impact of Event Scale [in Dutch]. Ned Tijdschr Psychol 40:164-168, 1985
19. Horowitz MJ: Stress-response syndromes: A review of posttraumatic and adjustment disorders. Hosp Community Psychiatry 37:241-249, 1986
20. Douma KF, Aaronson NK, Vasen HF, et al: Psychological distress and use of psychosocial support in familial adenomatous polyposis. Psychooncology 19:289-298, 2010
21. Lerman C, Kash K, Stefanek M: Younger women at increased risk for breast cancer: Perceived risk, psychological well-being, and surveillance behavior. Monogr Natl Cancer Inst 16:171-176, 1994
22. Ware JE, Sherbourne CD: The MOS 36-item short form health survey (SF-36): I: Conceptual framework and item selection. Med Care 30:473-483, 1992
23. Lerman C, Seay J, Balshem A, et al: Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385-392, 1995
24. Agustsdottir S, Kristinsdottir A, Jonsdottir K, et al: The impact of dispositional emotional expressivity and social constraints on distress among prostate cancer patients in Iceland. Br J Health Psychol, 2009
25. Lepore SJ: A social-cognitive processing model of emotional adjustment to cancer, in Baum A, Anderson B (eds): Psychosocial Interventions for Cancer. Washington DC, American Psychology Association, 2001, pp 99-118
26. Aaronson NK, Muller M, Cohen PD, et al: Translation, validation, and norming of the Dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 51:1055-1068, 1998 (Pubitemid 28527161)
27. Marteau TM, Croyle RT: The new genetics: Psychological responses to genetic testing. BMJ 316:693-696, 1998 (Pubitemid 28121038)
28. Bleiker EM, Aaronson NK, Menko FH, et al: Genetic counseling for hereditary cancer: A pilot study on experiences of patients and family members. Patient Educ Couns 32:107-116, 1997 (Pubitemid 27395985)
29. Tibben A, Frets PG, van de Kamp JJ, et al: Presymptomatic DNA-testing for Huntington disease: Pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 48:10-16, 1993 (Pubitemid 23119951)
30. Bleiker EMA, Menko FH, Kluijt I, et al: Colorectal cancer in the family: Psychosocial distress and social issues in the years following genetic counseling. Her Can in Clin Prac 5:59-66, 2007 (Pubitemid 47067605)
31. Meiser B, Halliday JL: What is the impact of genetic counseling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 54:1463-1470, 2002 (Pubitemid 34309011)
32. Keller M, Jost R, Haunstetter CM, et al: Comprehensive genetic counseling for families at risk for HNPCC: Impact on distress and perceptions. Genet Test 6:291-302, 2002 (Pubitemid 36020053)
33. Collins V, Halliday J, Warren R, et al: Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clin Genet 58:460-468, 2000 (Pubitemid 32000748)
34. Lepore S, Revenson T: Social constraints on disclosure and adjustment to cancer. Social and Personality Psychology Compass 1:313-333, 2007
35. Claes E, Denayer L, Evers-Kiebooms G, et al: Predictive testing for hereditary non-polyposis colorectal cancer: Motivation, illness representations and short-term psychological impact. Patient Educ Couns 55:265-274, 2004 (Pubitemid 39458227)
36. Lynch HT, Lemon SJ, Durham C, et al: A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 79:2219-2228, 1997 (Pubitemid 27227388)